{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:41:17Z","timestamp":1791996077354,"version":"4.4.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["01KI1017"],"award-info":[{"award-number":["01KI1017"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["01KN1106"],"award-info":[{"award-number":["01KN1106"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010368","name":"Paul-Ehrlich-Gesellschaft Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010368","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008792","name":"Novartis Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008792","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["KA 3104\/1-1"],"award-info":[{"award-number":["KA 3104\/1-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.jinf.2016.12.007","type":"journal-article","created":{"date-parts":[[2016,12,22]],"date-time":"2016-12-22T19:34:29Z","timestamp":1482435269000},"page":"248-259","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Determining vancomycin Etest MICs in patients with MRSA bloodstream infection does not support switching antimicrobials"],"prefix":"10.1016","volume":"74","author":[{"given":"Nina J.","family":"Hos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Jazmati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danuta","family":"Stefanik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Hellmich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halil","family":"AlSael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winfried V.","family":"Kern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siegbert","family":"Rieg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilmar","family":"Wisplinghoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Seifert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achim J.","family":"Kaasch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2016.12.007_bib1","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1056\/NEJM199902183400701","article-title":"Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group","volume":"340","author":"Smith","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jinf.2016.12.007_bib2","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1086\/346207","article-title":"Epidemiological and microbiological characterization of infections caused by Staphylococcus aureus with reduced susceptibility to vancomycin, United States, 1997\u20132001","volume":"36","author":"Fridkin","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2016.12.007_bib3","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1093\/jac\/dkr169","article-title":"Relevance of vancomycin-intermediate susceptibility and heteroresistance in methicillin-resistant Staphylococcus aureus bacteraemia","volume":"66","author":"Khatib","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2016.12.007_bib4","series-title":"Performance standards for antimicrobial susceptibility testing; twenty-fifty informational supplement","author":"CLSI","year":"2015"},{"key":"10.1016\/j.jinf.2016.12.007_bib5","unstructured":"EUCAST, http:\/\/www.eucast.org\/ [16 August 2016, date last accessed]."},{"key":"10.1016\/j.jinf.2016.12.007_bib6","unstructured":"BSAC. http:\/\/bsac.org.uk\/wp-content\/uploads\/2012\/02\/Version-11.1-2012-Final-.pdf [27 September 2015, date last accessed]."},{"key":"10.1016\/j.jinf.2016.12.007_bib7","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1128\/JCM.42.6.2398-2402.2004","article-title":"Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia","volume":"42","author":"Sakoulas","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jinf.2016.12.007_bib8","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1128\/AAC.00113-08","article-title":"Relationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin","volume":"52","author":"Lodise","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2016.12.007_bib9","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/01.md.0000091184.93122.09","article-title":"Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study","volume":"82","author":"Chang","year":"2003","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jinf.2016.12.007_bib10","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1086\/524667","article-title":"Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia","volume":"46","author":"Soriano","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2016.12.007_bib11","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1128\/JCM.00775-12","article-title":"Relationship between vancomycin-resistant Staphylococcus aureus, vancomycin-intermediate S. aureus, high vancomycin MIC, and outcome in serious S. aureus infections","volume":"50","author":"Holmes","year":"2012","journal-title":"J Clin Microbiol"},{"issue":"46 Suppl.","key":"10.1016\/j.jinf.2016.12.007_bib12","doi-asserted-by":"crossref","first-page":"S386","DOI":"10.1086\/533595","article-title":"Management of methicillin-resistant Staphylococcus aureus bacteremia","volume":"5","author":"Cosgrove","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2016.12.007_bib13","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1056\/NEJMoa053783","article-title":"Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus","volume":"355","author":"Fowler","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jinf.2016.12.007_bib14","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1093\/jac\/dkt234","article-title":"Vancomycin MIC as a predictor of outcome in MRSA bacteraemia in the UK context","volume":"68","author":"Hope","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2016.12.007_bib15","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1186\/1471-2334-11-335","article-title":"The impact of vancomycin susceptibility on treatment outcomes among patients with methicillin resistant Staphylococcus aureus bacteremia","volume":"11","author":"Honda","year":"2011","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jinf.2016.12.007_bib16","doi-asserted-by":"crossref","first-page":"5164","DOI":"10.1128\/AAC.00757-12","article-title":"Effect of reduced vancomycin susceptibility on clinical and economic outcomes in Staphylococcus aureus bacteremia","volume":"56","author":"Han","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2016.12.007_bib17","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1093\/jac\/dks128","article-title":"Vancomycin MICs do not predict the outcome of methicillin-resistant Staphylococcus aureus bloodstream infections in correctly treated patients","volume":"67","author":"Rojas","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2016.12.007_bib18","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1001\/jama.2014.6364","article-title":"Association between vancomycin minimum inhibitory concentration and mortality among patients with Staphylococcus aureus bloodstream infections: a systematic review and meta-analysis","volume":"312","author":"Kalil","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.jinf.2016.12.007_bib19","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1128\/CMR.05022-11","article-title":"Predictors of mortality in Staphylococcus aureus bacteremia","volume":"25","author":"van Hal","year":"2012","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jinf.2016.12.007_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/cid\/cir320","article-title":"Use of a simple criteria set for guiding echocardiography in nosocomial Staphylococcus aureus bacteremia","volume":"53","author":"Kaasch","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2016.12.007_bib21","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1055\/s-2008-1046715","article-title":"Epidemiology, course and prognosis of Staphylococcus aureus bacteremia \u2013 preliminary results from the INSTINCT (INvasive STaphylococcus aureus INfection CohorT) cohort","volume":"133","author":"Seifert","year":"2008","journal-title":"Dtsch Med Wochenschr"},{"key":"10.1016\/j.jinf.2016.12.007_bib22","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1128\/CMR.00042-09","article-title":"Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications","volume":"23","author":"Howden","year":"2010","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jinf.2016.12.007_bib23","unstructured":"Ridom SpaServer, http:\/\/www.spaserver.ridom.de [16 August 2016, date last accessed]."},{"key":"10.1016\/j.jinf.2016.12.007_bib24","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"10.1016\/j.jinf.2016.12.007_bib25","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/00003246-198510000-00009","article-title":"APACHE II: a severity of disease classification system","volume":"13","author":"Knaus","year":"1985","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jinf.2016.12.007_bib26","doi-asserted-by":"crossref","first-page":"791","DOI":"10.7326\/0003-4819-137-10-200211190-00007","article-title":"Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections","volume":"137","author":"Friedman","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jinf.2016.12.007_bib27","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jinf.2013.10.015","article-title":"Staphylococcus aureus bloodstream infection: a pooled analysis of five prospective, observational studies","volume":"68","author":"Kaasch","year":"2014","journal-title":"J Infect"},{"key":"10.1016\/j.jinf.2016.12.007_bib28","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1086\/313753","article-title":"Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis","volume":"30","author":"Li","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2016.12.007_bib29","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.jinf.2016.12.007_bib30","doi-asserted-by":"crossref","first-page":"4528","DOI":"10.1128\/AAC.00904-08","article-title":"Vancomycin MICs for methicillin-resistant Staphylococcus aureus isolates differ based upon the susceptibility test method used","volume":"52","author":"Prakash","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2016.12.007_bib31","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1093\/infdis\/jir270","article-title":"Antibiotic choice may not explain poorer outcomes in patients with Staphylococcus aureus bacteremia and high vancomycin minimum inhibitory concentrations","volume":"204","author":"Holmes","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jinf.2016.12.007_bib32","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1093\/cid\/cir858","article-title":"An association between bacterial genotype combined with a high-vancomycin minimum inhibitory concentration and risk of endocarditis in methicillin-resistant Staphylococcus aureus bloodstream infection","volume":"54","author":"Miller","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2016.12.007_bib33","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1086\/606027","article-title":"Heterogeneous vancomycin-intermediate susceptibility phenotype in bloodstream methicillin-resistant Staphylococcus aureus isolates from an international cohort of patients with infective endocarditis: prevalence, genotype, and clinical significance","volume":"200","author":"Bae","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jinf.2016.12.007_bib34","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1128\/AAC.05804-11","article-title":"Characterization of nasal and blood culture isolates of methicillin-resistant Staphylococcus aureus from patients in United States hospitals","volume":"56","author":"Tenover","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2016.12.007_bib35","doi-asserted-by":"crossref","first-page":"e1000215","DOI":"10.1371\/journal.pmed.1000215","article-title":"Geographic distribution of Staphylococcus aureus causing invasive infections in Europe: a molecular-epidemiological analysis","volume":"7","author":"Grundmann","year":"2010","journal-title":"PLoS Med"},{"key":"10.1016\/j.jinf.2016.12.007_bib36","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1128\/JCM.01579-08","article-title":"Methicillin-resistant Staphylococcus aureus in Spain: molecular epidemiology and utility of different typing methods","volume":"47","author":"Vindel","year":"2009","journal-title":"J Clin Microbiol"},{"issue":"48 Suppl.","key":"10.1016\/j.jinf.2016.12.007_bib37","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/jac\/48.suppl_1.5","article-title":"Determination of minimum inhibitory concentrations","volume":"1","author":"Andrews","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2016.12.007_bib38","series-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard-eighth edition","author":"CLSI","year":"2009"},{"key":"10.1016\/j.jinf.2016.12.007_bib39","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jinf.2015.12.009","article-title":"Clinical characteristics, treatment and outcomes of MRSA bacteraemia in the elderly","volume":"72","author":"Cuervo","year":"2016","journal-title":"J Infect"},{"key":"10.1016\/j.jinf.2016.12.007_bib40","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.1128\/JCM.01158-12","article-title":"Effects of storage on vancomycin and daptomycin MIC in susceptible blood isolates of methicillin-resistant Staphylococcus aureus","volume":"50","author":"Ludwig","year":"2012","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jinf.2016.12.007_bib41","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1128\/JCM.02302-10","article-title":"Performance of various testing methodologies for detection of heteroresistant vancomycin-intermediate Staphylococcus aureus in bloodstream isolates","volume":"49","author":"van Hal","year":"2011","journal-title":"J Clin Microbiol"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445316303371?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445316303371?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:23:52Z","timestamp":1759008232000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445316303371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S0163445316303371"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2016.12.007","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Determining vancomycin Etest MICs in patients with MRSA bloodstream infection does not support switching antimicrobials","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2016.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The British Infection Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}